The Incidence and Prognostic Significance of Humoral Hypercalcemia in Renal Cell Carcinoma-Reference-Cited by-同舟云学术

The Incidence and Prognostic Significance of Humoral Hypercalcemia in Renal Cell Carcinoma

Published:1991-02 Issue:2 Volume:145 Page:248-250
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Fahn Huei-Jyh¹,Lee Ying-Huei¹,Chen Ming-Tsun¹,Huang Jong-Khing¹,Chen Kuang-Kuo¹,Chang Luke S.¹

Affiliation:

1. From the Division of Urology, Department of Surgery, Veterans General Hospital, and National Yang-Ming Medical College, Taipei, Taiwan, Republic of China

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference20 articles.

1. Humoral hypercalcemia of cancer: identification of a novel parathyroid hormone-like peptide;Broadus;New Engl. J. Med.,1988

2. Humoral hypercalcemia of malignancy: involvement of a novel hormone;Martin;Aust. New Zeal. J. Med.,1988

3. Parathyroid hormone-like protein from human renal carcinoma cells: structural and functional homology with parathyroid hormone;Strewler;J. Clin. Invest.,1987

4. The hypercalcemia of malignancy: pathogenesis and management;Mundy;Metabolism,1982

5. Diagnosis and management of renal cell carcinoma: a clinical and pathological study of 309 cases;Skinner;Cancer,1971

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between parathyroid hormone-related peptide levels and mortality in patients with malignancy;Endocrine Practice;2024-09

2. Hypercalcemia in Urological Malignancies: A Review;Türk Üroloji Dergisi/Turkish Journal of Urology;2022-07-28

3. Clinicopathological and Preclinical Patient-Derived Model Studies Define High Expression of NRN1 as a Diagnostic and Therapeutic Target for Clear Cell Renal Cell Carcinoma;Frontiers in Oncology;2021-11-03

4. Functional inhibition of cancer stemness-related protein DPP4 rescues tyrosine kinase inhibitor resistance in renal cell carcinoma;Oncogene;2021-05-10

5. Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT;Programme Grants for Applied Research;2018-06